Park Inn, Cardiff North
Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 aflibercept (Eylea)
Minutes of the previous AWPAG meeting
National Prescribing Indicators 2016-2017 - Analysis of Prescribing Data to September 2016
National Prescribing Indicators 2017-2018
National Prescribing Indicators 2017-2018 - Supporting Information for Prescribers
Appraisal 2 human alpha1-proteinase inhibitor (Respreeza)
Appraisal 3 triptorelin (Decapeptyl SR)
Medicines Management Resource for Chronic Kidney Disease
CEPP National Audit - Medicines Management for Chronic Kidney Disease
Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 desmopressin lyophilisate (Noqdirna)
Appraisal 2 afamelanotide (Scenesse)
Minutes of the previous AWPAG meeting
Medicines identified as low priority for funding in NHS Wales
National Prescribing Indicators 2016-2017: Analysis of Prescribing Data to March 2017
Agenda
Minutes of the previous AWMSG meeting
Appraisal 1 lenvatinib (Lenvima)
Appraisal 2 glecaprevir/pibrentasvir (Maviret)
Appraisal 3 dolutegravir (Tivicay)
Appraisal 4 c1 inhibitor (Cinryze)
Appraisal 5 5-aminolaevulinic acid (Ameluz)
Appraisal 6 tiotropium (Spiriva Respimat)
Medicines identified as low priority for funding in NHS Wales